Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Patient-Reported Outcomes with Long-acting Cabotegravir and Rilpivirin

South Africa Time — Monday, August 10, 2026

Analyzed the health-related quality of life of people living with HIV receiving long-acting cabotegravir and rilpivirine and their healthcare ...

View article...

Racial Xperience

Top stories of the last 30 days

BioNTech Launches mRNA HIV Vaccine Trial

South Africa Time — Thursday, July 16, 2026

... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...

WCC will offer key input at International AIDS Conference in Brazil

South Africa Time — Thursday, July 23, 2026

Participants will include people living with HIV , researchers, policymakers, healthcare professionals, funders, media, and communities. Together, they ... View article...

HIV infections on the rise in Canada despite global decrease

South Africa Time — Thursday, July 30, 2026

Canada has all the tools it needs to end the HIV epidemic but the country is failing to do so because of a lack of funding, say experts. View article...

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging

South Africa Time — Tuesday, July 14, 2026

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV , ... View article...

Pakistan among 21 countries where new HIV infections are still rising

South Africa Time — Thursday, July 30, 2026

The proposed grant will support antiretroviral treatment, HIV testing, laboratory strengthening, medicines and diagnostics procurement, disease ... View article...

Lancet Report Recommends Paradigm Shift in Care for Older Adults with HIV

South Africa Time — Monday, July 27, 2026

Expanding care beyond essential antiviral therapy will help support growing older population with HIV expected to reach 20.2 million worldwide by ... View article...

Global HIV response at risk as funding cuts raise fears of epidemic resurgence

South Africa Time — Tuesday, July 28, 2026

Reductions in international funding and cuts to HIV prevention and community services are likely to lead to a resurgence of the HIV epidemic, ... View article...

Positive interim findings on new once-weekly HIV treatment pill

South Africa Time — Thursday, July 23, 2026

... antiretroviral formulation appears to be as effective as the daily pills. The new pill contains only two antiretrovirals , islatravir and lenacapavir. View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Gilead's Yeztugo beats forecasts as HIV PrEP franchise exceeds $1B

South Africa Time — Wednesday, August 05, 2026

Gilead said its twice-yearly HIV prevention shot Yeztugo generated $232 million in sales in the second quarter, topping Wall Street estimates of ... View article...

California's highest court rules for Gilead in 'duty to innovate' case

South Africa Time — Wednesday, August 05, 2026

Court orders dismissal of litigation by estimated 24,000 HIV patients · Gilead need not face negligence claims for halting development of alternative ... View article...

Game-changing HIV shot Lenacapavir draws thousands of first-time users in Western Cape

South Africa Time — Wednesday, August 05, 2026

... nearly 90% of those opting for the Lenacapavir injection are first-time users, marking a significant step forward in HIV prevention efforts. View article...

Montreal researchers develop new method for liver fibrosis screening among HIV patients

South Africa Time — Thursday, August 06, 2026

According to a study published in the Hepatology journal, researchers found that the commonly used FIB-4 blood test to detect scarring of liver tissue ... View article...

Funding cuts threaten HIV progress in Latin America, Caribbean

South Africa Time — Wednesday, August 05, 2026

LATIN America and the Caribbean recorded an estimated 153000 new HIV infections and 32800 AIDS-related deaths in 2025, as declining international ... View article...

Liver disease and HIV: Study reveals major gaps in liver fibrosis screening and offers a ...

South Africa Time — Thursday, August 06, 2026

The FIB- HIV score is a new tool developed by researchers at The Institute that could improve the identification of people at risk of liver ... View article...

How Cambodia became the first Asian country to hit an elusive HIV target

South Africa Time — Thursday, August 06, 2026

The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit the mark — until this ... View article...

HIV funding cuts raise concerns

South Africa Time — Thursday, August 06, 2026

Dr. Valeria Cantos explains how federal HIV funding cuts could affect patient care, prevention efforts and access to treatment in Georgia. View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews